ReadyCell News
Stay up-to-date on the latest ReadyCell news, projects and developments.
CacoReady permeability test, used to study a novel treatment against malignant cells
A new drug against malignant cells was found using methods such as High Throughput Screening (HTS) and Caco-2 permeability assay with CacoReady plates.
Happy Holiday Season from ReadyCell!
We want to send you our greetings and best wishes for the holiday season! This year, artists from the art studio of the AMPANS Foundation created a special Christmas card.
ReadyCell is attending the 7th Annual Drug Discovery Summit
The Drug Discovery Summit (DDS) includes high-level national and international speakers, interactive roundtables, knowledge-sharing panel sessions, workshops and networking.
Adari Cell visits ReadyCell’s facilities in Barcelona
The U.S. company Adari Cell Science met with ReadyCell at the Parc Científic de Barcelona and shared their impressions of the past year.
Play with us in the Science Week!
ReadyCell wants to contribute to the knowledge of science through scientific divulgation and didactics. For this purpose, we have prepared some games with scientific concepts to better understand processes.
ReadyCell has been accepted into the ICEX Next Program
ReadyCell SL in the context of the ICEX Next Program, has been supported by ICEX and co-financed by the European FEDER fund. The purpose of this support is to contribute to the international development of the company and its environment.
Cancer drug development: what to know about ABC transporters
The presence of the superfamily members of the ATP binding cassette (ABC) transporters is well established as the main cause of multidrug resistance, since they efflux therapeutic compounds from cells and reduce the intracellular drug levels.
Stretchbio holds a meeting in Denmark to evaluate the first 12 months of the project
Readycell participated in the annual meeting of the StretchBio Project, which was held at the Danmarks Tekniske Universitet (DTU) in Copenhagen.
A new study uses CacoGoblet in a gut-liver-organ-on-a-chip
An investigation led by the researcher Nicoló Milani was published in the prestigious analytical journal Lab on a Chip. The CacoGoblet kit was employed to investigate the permeability and the metabolism of the compound in a gut-liver-organ-on-a-chip (OoC).
ReadyCell is attending the 4th Brain Barriers Summit in Boston
Our ReadyCell sales representative Carla Sapienza will travel next August 29th, 30th and 31st to Boston to attend the Brain Barriers Summit, an event that aims to join industry experts through a discursive forum and evaluate how neuropharmaceuticals can be targeted.
New hyperoxia drug study references CacoReady Kits
The publication, entitled Daily Intraperitoneal Administration of RGZ Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia, was aimed at testing the efficacy of three types of Thiazolidenoides (TZN) in preterm rabbits with bronchopulmonary dysplasia.
Hepatic drug elimination: The role of OATPs and MRP2 transporters
OATP1B1 and OATP1B3 are two influx transporters of the SLCO gene family that are primarily expressed in the sinusoidal membrane of hepatocytes.
